Full name
ESMOKING INSTITUTE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
32 - Other manufacturing of products
58 - Publishing activities
59 - Activities related to film, video, television production, sound, and music recordings
63 - Services related to computing infrastructure, data processing, website management (hosting), and other information services
73 - Advertising, market research and public relations
74 - Other professional, scientific and technical activities
85 - Education
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,4 | 0 | 0 | 110,6 |
EBITDA | 1,4 | 0 | 0 | 29,4 |
Short time liabilities | 5,9 | 0 | 0 | 264,3 |
Equity capital | 2,9 | 0 | 0 | 23,8 |
Operating profit (EBIT) | 0,4 | 0 | 0 | 107,1 |
Assets | 9,6 | 0 | 0 | 117,7 |
Net profit (loss) | 0,4 | 0 | 0 | 149,8 |
Cash | 0,4 | 0 | 0 | 462,6 |
Net income from sale | 7,2 | 0 | 0 | 18,2 |
Liabilities and provisions for liabilities | 6,8 | 0 | 0 | 263,5 |
Working assets | 7,1 | 0 | 0 | 87,6 |
Depreciation | 1 | 0 | 0 | -5,6 |
% | % | % | p.p. | |
Profitability of capital | 13,4 | 9,5 | 19,2 | 9,7 |
Equity capital to total assets | 29,7 | 60,9 | 34,6 | -26,3 |
Gross profit margin | 5,2 | 6,2 | 11,1 | 4,9 |
EBITDA Margin | 20,1 | 22,1 | 24,2 | 2,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 300 | 72 | 221 | 149 |
Current financial liquidity indicator | 1.1060802936553955 | 1.2349433898925781 | 0.8236541152000427 | -0,4 |
Net dept to EBITDA | 0.5176646709442139 | -0.0069252075627446175 | 2.1943254470825195 | 2,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane